Cadila Pharma to set up three overseas manufacturing units
Days after opening its first overseas formulation manufacturing unit in Ethopia, the city- based Cadila Pharmaceuticals on Monday said it plans to set up similar projects in Europe, Middle-East and Asia to bolster exports.
By PTI |
AHMEDABAD: Days after opening its first overseas formulation manufacturing unit in Ethopia, the city- based Cadila Pharmaceuticals on Monday said it plans to set up similar projects in Europe, Middle-East and Asia to bolster exports.
"The first overseas manufacturing plant of Cadila has been set up in Ethopia. It will start commercial production from October 15", company's Chairman I A Modi said here.
"We are also planning to set up three or four more overseas manufacturing plants which could come up in the Middle-East, Asia or Europe in the coming years", Modi told reporters.
He, however, did not reveal the names of the countries where these plants were being planned.
These plants to be built in the future is expected on the lines of the manufacturing plant that Cadilla has set up in a joint venture with Almeta Impex Plc, Ethopia.
The plant in Ethopia, built at a cost of USD 10 million at Akaki near Addis Ababa, would function as a launch-pad for exports into other African nations.
We will be exporting almost 30 per cent of the production from this facility, said Modi, adding, initially three dosage forms - tablet, capsules and liquids - will be produced at the plant.
"The first overseas manufacturing plant of Cadila has been set up in Ethopia. It will start commercial production from October 15", company's Chairman I A Modi said here.
"We are also planning to set up three or four more overseas manufacturing plants which could come up in the Middle-East, Asia or Europe in the coming years", Modi told reporters.
He, however, did not reveal the names of the countries where these plants were being planned.
These plants to be built in the future is expected on the lines of the manufacturing plant that Cadilla has set up in a joint venture with Almeta Impex Plc, Ethopia.
The plant in Ethopia, built at a cost of USD 10 million at Akaki near Addis Ababa, would function as a launch-pad for exports into other African nations.
ADVERTISEMENT
We will be exporting almost 30 per cent of the production from this facility, said Modi, adding, initially three dosage forms - tablet, capsules and liquids - will be produced at the plant.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
